Assets in USD of Achilles Therapeutics plc from Q4 2020 to Q2 2024

Taxonomy & unit: us-gaap: USD
Description: Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.
Summary: Achilles Therapeutics plc quarterly Assets history and change rate from Q4 2020 to Q2 2024.
Achilles Therapeutics plc Assets for the quarter ending 30 Jun 2024 was $131M, a 33.7% decline year-over-year.

Assets, Quarterly (USD)

Assets, YoY Quarterly Change (%)

Achilles Therapeutics plc Quarterly Assets (USD)

Period	Value	YoY Chg	Change %	Date	Report	Filed
Q2 2024	$131M	-$66.7M	-33.7%	30 Jun 2024	6-K	14 Aug 2024
Q4 2023	$161M	-$58.9M	-26.7%	31 Dec 2023	6-K	14 Aug 2024
Q2 2023	$198M			30 Jun 2023	6-K	04 Aug 2023
Q4 2022	$220M	-$96.7M	-30.5%	31 Dec 2022	20-F	04 Apr 2024
Q4 2021	$317M	+$98.2M	+44.9%	31 Dec 2021	20-F	07 Mar 2023
Q4 2020	$219M			31 Dec 2020	20-F	01 Mar 2022

* An asterisk sign (*) next to the value indicates that the value is likely invalid.